Vaxcyte, Inc. 4

Vaxcyte CEO Grant Pickering surrendered 17,056 shares of common stock at about $60.36 per share to cover RSU tax withholding, retaining 429,902 direct shares plus children’s trust holdings.

On 2026-09-08, Vaxcyte, Inc. CEO Grant Pickering surrendered 17,056 shares of Vaxcyte common stock to the company in a transaction coded “F,” indicating a tax withholding event related to the vesting of previously granted RSUs. The shares were valued at approximately $60.36 per share, for an implied tax-cover value of about $1.03 million. Following this withholding transaction, Pickering continued to hold 429,902 shares directly, and an additional 133,215 shares are held indirectly in a trust for the benefit of his son and another 133,215 shares in a trust for the benefit of his daughter. As this is a routine, non-open-market disposition for tax purposes associated with equity compensation, it is generally less indicative of a discretionary change in insider sentiment than an open-market purchase or sale.

Filing Facts

CIK

1649094

Ticker

PCVX

Form

4

Source Type

fda

Accession

0001258693-26-000019

Alert Tier

5